Patents by Inventor Petra Prefot

Petra Prefot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis and prognosis of colorectal cancer
    Patent number: 9095549
    Abstract: The invention relates to a method of diagnosis of colorectal cancer in a diagnostic sample of a valid body tissue taken from a human subject, which comprises detecting an increased concentration of a protein in the diagnostic sample, compared with a control, normal human sample, the protein being: transforming growth factor-beta induced protein IG-H3 (SwissProt Acc. No. Q15582); suppressor of G2 allele of SKP1 homolog (isoform 2) (SwissProt Acc. No. Q9Y2Z0-2); hypothetical protein (part of URG4) (SwissProt Acc. No. Q9NWR7); calponin-2 (SwissProt Acc. No. Q99439); heat shock protein HSP90-beta (SwissProt Acc. No. P08238); phosphoglycerate mutase 1 (SwissProt Acc. No. P18669); serpin C1 protein (SwissProt Acc. No. P01008); or haptoglobin precursor (SwissProt Acc. No. P00738); or a decreased concentration of a protein in the diagnostic sample, compared with a control, normal human sample, the protein being serotransferrin (SwissProt Acc. No. P02787); 26S proteasome subunit p40.5 (Swiss Prot Acc. No.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: August 4, 2015
    Assignee: ELECTROPHORETICS LIMITED
    Inventors: Richard Joubert, Petra Prefot, Gitte Boehm, Juergen Arnhold, Claudia Hoehle, Erhard Neukum, Juergen Schaefer
  • METHODS OF DIAGNOSING ALZHEIMER'S DISEASE
    Publication number: 20110165146
    Abstract: Methods and compositions relating to Alzheimer's disease are provided. Specifically, proteins that are differentially expressed in the Alzheimer's disease state relative to their expression in the normal state are provided. Proteins associated with Alzheimer's disease are identified and described. Methods of diagnosis of Alzheimer's disease using the differentially expressed proteins are also provided, as are methods for the identification and therapeutic use of compounds for the prevention and treatment of Alzheimer's disease.
    Type: Application
    Filed: January 12, 2011
    Publication date: July 7, 2011
    Inventors: Jules Westbrook, Helen Byers, Malcolm Ward, Simon Lovestone, Abdul Hye, Stephen Lynham, Richard Joubert, Petra Prefot, Karsten Kuhn, Christian Baumann, Juergen Schaefer, Thorsten Prinz, Stefan Kienle
  • Methods of diagnosing Alzheimer's disease
    Patent number: 7897361
    Abstract: Methods and compositions relating to Alzheimer's disease are provided. Specifically, proteins that are differentially expressed in the Alzheimer's disease state relative to their expression in the normal state are provided. Proteins associated with Alzheimer's disease are identified and described. Methods of diagnosis of Alzheimer's disease using the differentially expressed proteins are also provided, as are methods for the identification and therapeutic use of compounds for the prevention and treatment of Alzheimer's disease.
    Type: Grant
    Filed: September 29, 2005
    Date of Patent: March 1, 2011
    Inventors: Jules Westbrook, Helen Byers, Malcolm Ward, Simon Lovestone, Abdul Hye, Stephen Lynham, Richard Joubert, Petra Prefot, Karsten Kuhn, Christian Baumann, Juergen Schaefer, Thorsten Prinz, Stefan Kienle
  • DIAGNOSIS AND PROGNOSIS OF COLORECTAL CANCER
    Publication number: 20090226905
    Abstract: The invention relates to a method of diagnosis of colorectal cancer in a diagnostic sample of a valid body tissue taken from a human subject, which comprises detecting an increased concentration of a protein in the diagnostic sample, compared with a control, normal human sample, the protein being: transforming growth factor-beta induced protein IG-H3 (SwissProt Acc. No. Q15582); suppressor of G2 allele of SKP1 homolog (isoform 2) (SwissProt Acc. No. Q9Y2Z0-2); hypothetical protein (part of URG4) (SwissProt Acc. No. Q9NWR7); calponin-2 (SwissProt Acc. No. Q99439); heat shock protein HSP90-beta (SwissProt Acc. No. P08238); phosphoglycerate mutase 1 (SwissProt Acc. No. P18669); serpin Cl protein (SwissProt Acc. No. P01008); or haptoglobin precursor (SwissProt Acc. No. P00738); or a decreased concentration of a protein in the diagnostic sample, compared with a control, normal human sample, the protein being serotransferrin (SwissProt Acc. No. P02787); 26S proteasome subunit p40.5 (Swiss Prot Acc. No.
    Type: Application
    Filed: December 15, 2006
    Publication date: September 10, 2009
    Inventors: Richard Joubert, Petra Prefot, Gitte Boehm, Juergen Arnhold, Claudia Hoehle, Erhard Neukum, Juergen Schaefer
  • Methods and Compositions Relating to Alzheimer's Disease
    Publication number: 20080070995
    Abstract: Methods and compositions relating to Alzheimer's disease are provided. Specifically, proteins that are differentially expressed in the Alzheimer's disease state relative to their expression in the normal state are provided. Proteins associated with Alzheimer's disease are identified and described. Methods of diagnosis of Alzheimer's disease using the differentially expressed proteins are also provided, as are methods for the identification and therapeutic use of compounds for the prevention and treatment of Alzheimer's disease.
    Type: Application
    Filed: September 29, 2005
    Publication date: March 20, 2008
    Inventors: Jules Westbrook, Helen Byers, Malcolm Ward, Simon Lovestone, Abdul Hye, Stephen Lynham, Richard Joubert, Petra Prefot, Karsten Kuhn, Christian Baumann, Juergen Schaefer, Thorsten Prinz, Stefan Kienle